Sexually Dimorphic Relationships Among Saa3 (Serum Amyloid A3), Inflammation, and Cholesterol Metabolism Modulate Atherosclerosis in Mice
暂无分享,去创建一个
A. Chait | A. Lusis | S. Gharib | T. Vaisar | L. Goodspeed | K. O’Brien | Jingjing Tang | Chongren Tang | T. Wietecha | K. Rubinow | L. D. den Hartigh | C. Storey | Shari Wang | D. Gomes | Katherine E. Turk | Laura J. den Hartigh
[1] T. Jones,et al. Testosterone stimulates cholesterol clearance from human macrophages by activating LXRα. , 2021, Life sciences.
[2] Mireya Becerra-Díaz,et al. Androgen and Androgen Receptors as Regulators of Monocyte and Macrophage Biology in the Healthy and Diseased Lung , 2020, Frontiers in Immunology.
[3] M. Cybulsky,et al. Meta-Analysis of Leukocyte Diversity in Atherosclerotic Mouse Aortas , 2020, Circulation research.
[4] W. Altemeier,et al. Presence of serum amyloid A3 in mouse plasma is dependent on the nature and extent of the inflammatory stimulus , 2020, Scientific Reports.
[5] C. Glass,et al. Niche-Specific Reprogramming of Epigenetic Landscapes Drives Myeloid Cell Diversity in Nonalcoholic Steatohepatitis. , 2020, Immunity.
[6] L. Willemsen,et al. Macrophage subsets in atherosclerosis as defined by single‐cell technologies , 2020, The Journal of pathology.
[7] K. Bandow,et al. Caldecrin inhibits lipopolysaccharide-induced pro-inflammatory cytokines and M1 macrophage polarization through the immunoreceptor triggering receptor expressed in myeloid cells-2. , 2020, Biochemical and biophysical research communications.
[8] Steve Lianoglou,et al. TREM2 Regulates Microglial Cholesterol Metabolism upon Chronic Phagocytic Challenge , 2019, Neuron.
[9] C. Ponting,et al. Resolving the fibrotic niche of human liver cirrhosis at single cell level , 2019, Nature.
[10] P. Libby,et al. Low‐Dose Methotrexate for the Prevention of Atherosclerotic Events , 2019, The New England journal of medicine.
[11] P. McNamara,et al. Serum Amyloid A Is an Exchangeable Apolipoprotein , 2018, Arteriosclerosis, thrombosis, and vascular biology.
[12] P. Shridas,et al. High-density lipoprotein inhibits serum amyloid A–mediated reactive oxygen species generation and NLRP3 inflammasome activation , 2018, The Journal of Biological Chemistry.
[13] Dennis Wolf,et al. Single-Cell RNA-Seq Reveals the Transcriptional Landscape and Heterogeneity of Aortic Macrophages in Murine Atherosclerosis , 2018, Circulation research.
[14] T. Jones,et al. Randomized controlled trials – mechanistic studies of testosterone and the cardiovascular system , 2018, Asian journal of andrology.
[15] J. Ather,et al. Serum amyloid A3 is required for normal weight and immunometabolic function in mice , 2018, PloS one.
[16] P. Shridas,et al. Serum amyloid A3 is pro-atherogenic. , 2018, Atherosclerosis.
[17] P. Libby,et al. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease , 2017, The New England journal of medicine.
[18] M. Koschinsky,et al. Plasminogen promotes cholesterol efflux by the ABCA1 pathway. , 2017, JCI insight.
[19] P. Scherer,et al. Serum Amyloid A3 Gene Expression in Adipocytes is an Indicator of the Interaction with Macrophages , 2016, Scientific Reports.
[20] G. Getz,et al. Serum amyloid A and atherosclerosis , 2016, Current opinion in lipidology.
[21] M. Harada‐Shiba,et al. Association Between Cholesterol Efflux Capacity and Atherosclerotic Cardiovascular Disease in Patients With Familial Hypercholesterolemia , 2016, Arteriosclerosis, thrombosis, and vascular biology.
[22] S. Subramanian,et al. Serum amyloid A impairs the antiinflammatory properties of HDL. , 2016, The Journal of clinical investigation.
[23] Brian J. Bennett,et al. Genetic Architecture of Atherosclerosis in Mice: A Systems Genetics Analysis of Common Inbred Strains , 2015, PLoS genetics.
[24] A. Masi,et al. Sexual Dimorphisms of Adrenal Steroids, Sex Hormones, and Immunological Biomarkers and Possible Risk Factors for Developing Rheumatoid Arthritis , 2015, International journal of endocrinology.
[25] T. Vaisar,et al. Inflammatory remodeling of the HDL proteome impairs cholesterol efflux capacity[S] , 2015, Journal of Lipid Research.
[26] G. Getz,et al. Serum Amyloid A Facilitates Early Lesion Development in Ldlr−/− Mice , 2015, Journal of the American Heart Association.
[27] Lindsey A. Muir,et al. Differences in Hematopoietic Stem Cells Contribute to Sexually Dimorphic Inflammatory Responses to High Fat Diet-induced Obesity* , 2015, The Journal of Biological Chemistry.
[28] G. Paulsson-Berne,et al. The role of the FPR2/ALX receptor in atherosclerosis development and plaque stability , 2014, Cardiovascular research.
[29] S. Subramanian,et al. Deletion of Serum Amyloid A3 Improves High Fat High Sucrose Diet-Induced Adipose Tissue Inflammation and Hyperlipidemia in Female Mice , 2014, PloS one.
[30] K. Migita,et al. Serum Amyloid A Induces NLRP-3-Mediated IL-1β Secretion in Neutrophils , 2014, PloS one.
[31] A. Daugherty,et al. Deficiency of Endogenous Acute Phase Serum Amyloid A Does Not Affect Atherosclerotic Lesions in Apolipoprotein E–Deficient Mice , 2014, Arteriosclerosis, thrombosis, and vascular biology.
[32] A. Goldberg,et al. Decrease of Circulating SAA is Correlated with Reduction of Abdominal SAA Secretion During Weight Loss , 2013, Obesity.
[33] Jason M. Meyer,et al. The Impairment of Macrophage-to-Feces Reverse Cholesterol Transport during Inflammation Does Not Depend on Serum Amyloid A , 2013, Journal of lipids.
[34] M. Rizzo,et al. Recent Insights Into the Relationship Between Inflammatory Liver Diseases and Atherosclerosis , 2011, Journal of Investigative Medicine.
[35] Katherine A. Fitzgerald,et al. Serum Amyloid A Activates the NLRP3 Inflammasome and Promotes Th17 Allergic Asthma in Mice , 2011, The Journal of Immunology.
[36] Robert L Wilensky,et al. Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. , 2011, The New England journal of medicine.
[37] C. Zhang,et al. Serum Amyloid A Directly Accelerates the Progression of Atherosclerosis in Apolipoprotein E-Deficient Mice , 2011, Molecular medicine.
[38] A. Villablanca,et al. Atherosclerosis and sex hormones: current concepts. , 2010, Clinical science.
[39] J. Eriksson,et al. Association of serum amyloid A levels with adipocyte size and serum levels of adipokines: differences between men and women. , 2009, Cytokine.
[40] P. Witting,et al. Serum amyloid A induction of cytokines in monocytes/macrophages and lymphocytes. , 2009, Atherosclerosis.
[41] Muredach P. Reilly,et al. Inflammation Impairs Reverse Cholesterol Transport In Vivo , 2009, Circulation.
[42] M. Fasshauer,et al. The adipokine SAA3 is induced by interleukin‐1β in mouse adipocytes , 2008, Journal of cellular biochemistry.
[43] Age K Smilde,et al. Atherosclerosis and liver inflammation induced by increased dietary cholesterol intake: a combined transcriptomics and metabolomics analysis , 2007, Genome Biology.
[44] S. Umemura,et al. Serum amyloid A is a better predictor of clinical outcomes than C-reactive protein in non-ST-segment elevation acute coronary syndromes. , 2007, Circulation journal : official journal of the Japanese Circulation Society.
[45] Da-Wei Gong,et al. Acute-Phase Serum Amyloid A: An Inflammatory Adipokine and Potential Link between Obesity and Its Metabolic Complications , 2006, PLoS medicine.
[46] A. Chait,et al. Serum Amyloid A and Lipoprotein Retention in Murine Models of Atherosclerosis , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[47] P. Svensson,et al. A microarray search for genes predominantly expressed in human omental adipocytes: adipose tissue as a major production site of serum amyloid A. , 2005, The Journal of clinical endocrinology and metabolism.
[48] K. Clément,et al. Serum amyloid A: production by human white adipocyte and regulation by obesity and nutrition , 2005, Diabetologia.
[49] A. Chait,et al. Increase in Serum Amyloid A Evoked by Dietary Cholesterol Is Associated With Increased Atherosclerosis in Mice , 2004, Circulation.
[50] S. Reis,et al. Serum Amyloid A as a Predictor of Coronary Artery Disease and Cardiovascular Outcome in Women: The National Heart, Lung, and Blood Institute–Sponsored Women’s Ischemia Syndrome Evaluation (WISE) , 2004, Circulation.
[51] A. Whitehead,et al. Serum amyloid A, the major vertebrate acute-phase reactant. , 1999, European journal of biochemistry.
[52] K. Williams,et al. Atherosclerosis--an inflammatory disease. , 1999, The New England journal of medicine.
[53] J. Rotter,et al. Association between serum amyloid A proteins and coronary artery disease: evidence from two distinct arteriosclerotic processes. , 1997, Circulation.
[54] H. Khalili,et al. Estradiol Down‐Regulates LPS‐Induced Cytokine Production and NFkB Activation in Murine Macrophages , 1997, American journal of reproductive immunology.
[55] M. Frazier-Jessen,et al. Estrogen modulation of JE/monocyte chemoattractant protein-1 mRNA expression in murine macrophages. , 1995, Journal of immunology.
[56] R. Badolato,et al. Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes , 1994, The Journal of experimental medicine.
[57] S. Urieli-Shoval,et al. Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid A function. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[58] N. Eriksen,et al. Murine serum amyloid A3 is a high density apolipoprotein and is secreted by macrophages. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[59] M. Drumm,et al. Nonexpression of the human serum amyloid A three (SAA3) gene. , 1991, DNA and cell biology.
[60] R. Meek,et al. Amyloid A gene family expression in different mouse tissues , 1986, The Journal of experimental medicine.
[61] J. Sipe,et al. Murine model for human secondary amyloidosis: genetic variability of the acute-phase serum protein SAA response to endotoxins and casein , 1976, The Journal of experimental medicine.